Summit Wealth & Retirement Planning’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
CS
Summit Wealth & Retirement Planning's GH Position: Q4 2022 in Review
Summit Wealth & Retirement Planning sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,362 shares — an estimated $235K sold.
Summit Wealth & Retirement Planning first reported a position in GH in Q4 2019 and held it in 11 quarters. The position peaked at $959K in Q4 2020. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.
- Summit Wealth & Retirement Planning reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
- Summit Wealth & Retirement Planning sold 4,362 Guardant Health shares in Q4 2022, an estimated $235K.
- Summit Wealth & Retirement Planning first reported a position in Guardant Health in Q4 2019 and held it in 11 quarters.
- Summit Wealth & Retirement Planning's Guardant Health position peaked at $959K in Q4 2020.
- 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.
Based on Summit Wealth & Retirement Planning's 13F filing for Q4 2022, filed 10 Feb 2023.